Callan JMB expands U.S. pharmaceutical manufacturing and distribution

Approximately $28 million in planned TRUKING equipment advances domestic manufacturing capacity, strengthens the Company's preparedness strategy, and supports new commercial opportunities SPRING BRANCH, Texas, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB" or the "Company"), a diversified preparedness, logistics, and critical-infrastructure company, today announced progress toward establishing domestic pharmaceutical manufacturing at the Atlas Complex in Marion, Alabama, through an equipment procurement and distribution collaboration with TRUKING. The Company has signed an initial purchase order and expects to make a $500,000 down payment toward approximately $28 million in pharmaceutical manufacturing equipment planned for installation at Atlas. The collaboration also provides for Callan JMB to serve as a North American distributor and assembly provider for TRUKING equipment. This role extends the Company's participation beyond the initial Atlas deployment to equipment distribution and assembly for additional planned pharmaceutical manufacturing sites and other commercial customers. The initiative builds on Callan JMB's longstanding emergency-preparedness and response work by connecting planned domestic pharmaceutical production with the logistics, regulatory compliance, specialty packaging, warehousing, monitoring, and distribution capabilities used to protect and deliver critical supplies. Bringing these functions together at the Atlas Complex in Marion, Alabama is intended to support continuity of supply during routine operations and periods of heightened demand or disruption. Equipment distribution and assembly would also broaden the Company's commercial participation in the infrastructure supporting pharmaceutical manufacturing. "Our work in preparedness and response has always depended on knowing how to source critical products, protect their integrity, and get them where they are needed," said Wayne Williams, Chief Executive Officer of Callan JMB. "Developing pharmaceutical manufacturing at the Atlas Complex extends that experience further into the supply chain. By connecting U.S. production with our logistics and distribution capabilities, we aim to strengthen the availability of essential products before an emergency and support resupply when demand increases. Our role with TRUKING also creates an opportunity to support additional manufacturing projects and commercial customers." The initial equipment deployment is being coordinated with development of the planned 90,000-square-foot Marion 9 manufacturing facility at the Atlas Complex. The facility is intended to support U.S. production of pharmaceutical products affected by critical supply shortages, with equipment fabrication and facility construction expected to proceed in parallel. TRUKING is an international supplier of pharmaceutical equipment and integrated manufacturing solutions. The collaboration brings its specialized equipment capabiliti